Black Diamond Therapeutics (BDTX) Earnings Date & Reports

Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

BDTX is expected to report earnings to rise 22.13% to -19 cents per share on August 06

Black Diamond Therapeutics BDTX Stock Earnings Reports

Q2'26

Est.

$-0.20

Q1'26

Beat

by $0.03

Q4'25

Missed

by $0.10

Q3'25

Beat

by $0.08

Q2'25

Beat

by $0.06

The last earnings report on May 07 showed earnings per share of -15 cents, beating the estimate of -18 cents. With 1.16M shares outstanding, the current market capitalization sits at 92.54M.

View a ticker or compare two or three

Compare

BDTX

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for BDTX